CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at help@airdberlis.com.

Back to all publications
Jul 17, 2020

The Canadian Intellectual Property Office’s COVID-19 Response

By Erica L. Lowthers, PhD

Like many other jurisdictions, the Canadian Intellectual Property Office (CIPO) has implemented extensions of time for certain deadlines relating to patents, industrial designs and trademarks due to COVID-19. These extensions have been ongoing since March 16, 2020, and are currently set to end on August 28, 2020, meaning that certain due dates falling between March 16 and August 28, inclusive, are automatically extended to August 31. The CIPO website details how CIPO operations are being modified in view of COVID-19.

Despite these extensions being available, we recommend that all original due dates be met if possible. The extensions do not apply to all due dates and, in some cases, extensions are only available up to certain maximum time periods. Please reach out to one of our professionals if you need to discuss a particular matter.

CIPO remains open for business, but has warned of significant delays in their services while most of their staff is working remotely.

In order to encourage innovation surrounding COVID-19 inventions, CIPO has launched a pilot program for free accelerated examination of Canadian patent applications that pertain to supporting the health-related response to COVID-19. This program is limited to 50 applications for the time being and is targeted to Applicants that qualify as a small entity (a business employing 50 or fewer employees or a university) and in which the claimed invention is currently or has been subject to a Health Canada approval process.

The professionals of Aird & McBurney can help you navigate patent, industrial design and trademark applications. Details are available on our Intellectual Property webpage.

Related Publications

Publications Article
Rethinking Diversity in Canada’s Capital Markets: Beyond Gender By Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Angela Oh Nov 29, 2021 Almost seven years following the adoption of the gender focused corporate governance disclosure r... Almost seven years following the adoption of the gender focused corporate governance disclosure rules set out in National Instrument 58-101 Disclosure of Corporate Governance Practices, recent data published by the Canadian Securities Administrators in Multilateral Staff Notice 58-313 Review o...
Publications Article
Modernizing Ontario’s Capital Markets: Capital Markets Act (Ontario) By Melanie Cole, Meredith McCann and Portia Biswas Nov 29, 2021 On October 12, 2021, the Government of Ontario published the draft Capital Markets Act, which is ... On October 12, 2021, the Government of Ontario published the draft Capital Markets Act, which is designed to streamline and modernize the regulatory framework of the province’s capital markets. If approved, the CMA will replace both the Securities Act (Ontario) and the Commodity Futures A...
Publications Article
Excess Claims Fees to Be Introduced Into Canada’s Patent Regime By Tony Sabeta, B.Eng. Nov 25, 2021 The Canadian patent regime has always been unique and flexible. However, many of these unique asp... The Canadian patent regime has always been unique and flexible. However, many of these unique aspects are disappearing in order to bring Canada’s patent regime into procedural harmony with the practice in other jurisdictions.